BGC Priv Journal
Photo
alot starting to break up out that "boot" pattern/wedge
BGC Priv Journal
ppl laugh whenever i say im bullish moodeng, but look at that chart bro. things can change quick, if u trade moodeng u know how violent it is, rly think its one of those coins that can just go god mode out of no where in like 2 candles don't doubt theres…
i blame all of this on moodeng
🤣1
monad kind of giving off canton vibes. also notice it regularly showing strength
was looking through alts, most of them look like the above.
The current bounce broke their *post 10/10 down trending structure (defined by rsi/ma's) on this current bounce. During the pullback, a lot retested mid-ranges and rsi pull back to retest the "breakout".
lets see if it holds goin forward
The current bounce broke their *post 10/10 down trending structure (defined by rsi/ma's) on this current bounce. During the pullback, a lot retested mid-ranges and rsi pull back to retest the "breakout".
lets see if it holds goin forward
I rly like NVO - break up was the new that their oral product was approved. They've been moving incrementally surprising analysts with their speed to production.
I'm not a healthcare expert but oral massively expands GLP TAM IMO. LLY will have one at some point ofc, but nvo being first to market gives it room for these catalysts to give incremental upside before lly comes to market (even when they do there's room for both imo).
Its also very under-owned compared to LLY, LO's probably start to OW incrementally bc having a "defensive" position w/growth catalysts is an attractive bet to have in the port rn. At the same time, HF's probably unwinding the Long LLY / Short NVO trade boosting the stock a bit more
healthcare, so defensive positioning + growth catalyst and 2.8% yield to wait.
NFA DYODD
I'm not a healthcare expert but oral massively expands GLP TAM IMO. LLY will have one at some point ofc, but nvo being first to market gives it room for these catalysts to give incremental upside before lly comes to market (even when they do there's room for both imo).
Its also very under-owned compared to LLY, LO's probably start to OW incrementally bc having a "defensive" position w/growth catalysts is an attractive bet to have in the port rn. At the same time, HF's probably unwinding the Long LLY / Short NVO trade boosting the stock a bit more
healthcare, so defensive positioning + growth catalyst and 2.8% yield to wait.
NFA DYODD
❤1